/
Its mattresses are designed to evolve with each sleeper to help them feel and perform their best. With adjustable firmness, pressure-relieving support and temperature balancing comfort built into every mattress, Sleep Number beds adapt to customers changing needs, night after night, year after year.
$0.03
+$0.00 (+1.92%)
EOD Jul 17, 2026
The business is unprofitable at the operating level (-3.30% margin). The thesis depends entirely on whether and when it reaches sustainable profitability.
Revenue declined 16.1% YoY. Margins deteriorated 4.7pp alongside, both lines moving the wrong way.
Free cash flow declined 586% versus the prior year, cash generation momentum has weakened. ROIC dropped from 1.89% to -3.92%, capital efficiency is deteriorating.
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue (TTM)
$1.34B
▼ -16.1% YoY
Net Income (TTM)
-$174M
▼ -549.0% YoY
Op. Margin
-6.38%
▼ -4.7pp YoY
ROIC
-7.15%
▼ -5.8pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
-$24M
▼ -586.3% YoY
Op. Cash Flow (TTM)
-$8M
▼ -112.1% YoY
Net Debt
$952M
Cash & Equiv.
$1M
5Y CAGR: -5.3%
Continue Research
Sleep Number (SNBR)'s valuation is best read against its own history, its peers, and the growth its price implies. A high multiple is not the same as overvalued: fast-growing, high-quality businesses can deserve a premium. See the general approach in how to tell if a stock is overvalued.
On quality, Sleep Number scores 6/100 on Intrinsiqq's quality scorecard (a lower-quality business on these measures), weighing growth, margins, returns on capital, share count, and balance-sheet strength. All figures are computed from SEC filings; read the full . This is analysis, not investment advice.
Sleep Number scores 6 out of 100 on Intrinsiqq's quality score, a weighted blend of 6 metrics each scored 0 to 100, which makes it a lower-quality business on these measures. Recent fundamentals include a -6.4% operating margin and a -7.1% return on invested capital. The score weighs revenue and free-cash-flow growth, operating margins, return on invested capital, share-count change, and balance-sheet strength, all computed from SEC filings, not opinion. Because valuation only means something relative to quality, the full metric-by-metric breakdown is on the quality scorecard.
That depends on valuation and quality together, not either alone. you should weigh SNBR's valuation and scores 6/100 on quality (lower-quality). A cheap price is only a bargain if the business is durable, and a premium can be justified by genuine quality, so the two questions, "is it cheap?" and "is it good?", only make sense side by side. Read the valuation against the quality scorecard, run the DCF on your own assumptions, and decide for yourself. This is analysis from SEC filings, not investment advice.